MindWalk says AI models are replaceable. Can ReefIQ make biological context the real drug discovery moat?
MindWalk debuts ReefIQ on AMD Instinct, testing whether governed biological context can become the infrastructure moat in AI drug discovery.
Medical Devices & Diagnostics
Pharma & Biotech
MindWalk adds VHH capability as nanobodies gain ground in CAR-T and multispecific design
MindWalk launches B Cell Llama, a VHH nanobody platform for bispecific drug design. Peer-reviewed data raises key questions about function, immunogenicity, and AI.